Edge Medical Ventures

Edge Medical Ventures is an Israeli medtech fund and venture studio operating from Or Yehuda, focused on surgical and cardiovascular device platforms. The studio model means the firm sometimes co-builds rather than purely backs companies, leveraging clinical relationships to construct device platforms around specific procedural problems. Founders working in operating-room workflows, cardiovascular interventions, or other procedural devices will find a clearer match here than digital health or population health AI teams.

Stages are Seed, Series A, and Series B, with check sizes between $1 million and $5 million. The sub-vertical focus is medical devices. The record does not identify named portfolio companies, but the studio orientation typically means a smaller portfolio with higher per-company involvement than a standard VC. Geographic activity is concentrated in Israel.

For healthcare AI founders, the relevant question is whether the AI sits inside a surgical or cardiovascular device system. Pure software products without a hardware or procedural anchor are unlikely to fit. Founders should expect hands-on engagement, including clinical advisory access and operational involvement at the studio level, which is valuable but reduces the operating autonomy that some software-first teams prefer. A strong Israeli clinical site relationship and a clear regulatory pathway through FDA or CE Mark will materially help the pitch.